Innovita Biological Technology Co. Ltd. A (688253.SS) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100005Q14

Price
49.20 CNY
Market cap
6.74 bn CNY
P/E (2025)
46.65
P/S (2025)
15.97
Dividend yield
0.91 %
Net margin
34.23 %
Return on equity (ROE)
7.04 %
Return on assets (ROA)
6.35 %

Innovita Biological Technology Co. Ltd. A financials

Fiscal year20242025
Revenue621.39 m CNY422.03 m CNY
Gross profit497.88 m CNY330.35 m CNY
Operating income248.93 m CNY128.89 m CNY
EBIT276.64 m CNY159.82 m CNY
Net income246.86 m CNY144.47 m CNY
Diluted EPS – continuing operations1.81 CNY1.05 CNY

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Innovita Biological Technology Co. Ltd. A

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products. It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing. The company was founded in 2006 and is based in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.